Comparable stake leader
RENAISSANCE TECHNOLOGIES LLC
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000910329.
Comparable stake leader
RENAISSANCE TECHNOLOGIES LLC
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
26 May 2026
Ownership snapshot
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Quick read
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC |
13D/G
13F
Company
|
7%
|
$8,139,429
773,710 shares
|
-$1,212,093 | 02 Jan 2026 |
| Citadel Securities GP LLC |
13D/G
|
6.5%
|
$7,531,373
715,910 shares
|
$0 | 31 Mar 2026 |
| Steamboat Capital Partners, LLC |
13F
13D/G
Company
|
6%
from 13D/G
|
$7,210,342
707,590 shares
|
— | 31 Mar 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
13D/G
Company
|
5.7%
from 13D/G
|
$6,435,382
631,539 shares
|
— | 31 Mar 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
2.9%
from 13D/G
|
$9,623,975
944,453 shares
|
— | 31 Mar 2026 |
| SUSQUEHANNA SECURITIES, LLC |
13D/G
G1 Execution Services, LLC
|
1.4%
|
$1,741,155
148,944 shares
|
-$5,915,152 | 31 Dec 2025 |
| Parsa Kiai |
3/4/5
Director
|
6.1%
|
$7,100,357
693,910 shares
|
— | 26 May 2026 |
| Daniel R. Chard |
3/4/5
Chairman & CEO, Director
|
3.1%
|
$3,787,830
355,609 shares
|
+$178,725 | 13 Mar 2026 |
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Net insider flow leans to buying over the last 12 months. Net value: +$241,675.
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 5,000 | 0 | $62,950 | $0 | +$62,950 |
| 3-6 | 17,678 | 0 | $178,725 | $0 | +$178,725 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Showing 1-14 of 14 reporting-owner rows connected to MEDIFAST INC. Open a relationship link for the CIK-to-CIK filing trail.
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Parsa Kiai | Director | $7,100,357 | Mixed | 26 May 2026 | ||
| Daniel R. Chard | Chairman & CEO, Director | $3,787,830 | +$178,725 | +5% | Mixed | 13 Mar 2026 |
| Kevin G. Byrnes | Director | $1,027,977 | Mixed | 11 Nov 2021 | ||
| James P. Maloney | Chief Financial Officer | $779,992 | Mixed | 13 Mar 2026 | ||
| Jeffrey J. Brown | Director | $573,487 | Mixed | 25 Jun 2025 | ||
| Ming Xian | Director | $430,393 | Mixed | 26 May 2026 | ||
| Scott Schlackman | Director | $430,310 | +$62,950 | +17% | Mixed | 26 May 2026 |
| Andrea B. Thomas | Director | $363,753 | Mixed | 26 May 2026 | ||
| Michael A. Hoer | Director | $351,575 | Mixed | 25 Jun 2025 | ||
| Elizabeth A. Geary | Director | $318,182 | Mixed | 26 May 2026 | ||
| Jonathan Barrett MacKenzie | VP, Finance & CAO | $222,549 | Mixed | 13 Mar 2026 | ||
| Nicholas Mark Johnson | President | $195,833 | Mixed | 05 Jan 2026 | ||
| Jeffrey Matthew Rose | Director | $187,689 | Mixed | 26 May 2026 | ||
| Constance J. Hallquist | Former Director | $148,251 | Mixed | 06 Oct 2023 |
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Jeffrey Matthew Rose | MED | Common Stock | Award | 18,419 | 18,419 | 26 May 2026 | Direct | |||
| Parsa Kiai | MED | Common Stock | Award | 19,317 | 19,317 | 26 May 2026 | Direct | |||
| Andrea B. Thomas | MED | Common Stock | Award | 48.6% | 11,680 | 35,697 | 26 May 2026 | Direct | ||
| Scott Schlackman | MED | Common Stock | Award | 38.2% | 11,680 | 42,229 | 26 May 2026 | Direct | ||
| Elizabeth A. Geary | MED | Common Stock | Award | 59.8% | 11,680 | 31,225 | 26 May 2026 | Direct | ||
| Ming Xian | MED | Restricted Stock Units (cash settled) | Award | 36.3% | 11,680 | 43,823 | 26 May 2026 | Direct | ||
| Scott Schlackman | MED | Common Stock | Purchase | 8.91% | $31,325 | $12.53 | 2,500 | 30,549 | 11 May 2026 | Direct |
| Scott Schlackman | MED | Common Stock | Purchase | 9.79% | $31,625 | $12.65 | 2,500 | 28,049 | 08 May 2026 | Direct |
| Jonathan Barrett MacKenzie | MED | Common Stock | Award | 108.2% | 10,830 | 20,838 | 25 Mar 2026 | Direct | ||
| Jonathan Barrett MacKenzie | MED | Common Stock | Tax liability | -7.93% | -862 | 10,008 | 25 Mar 2026 | Direct | ||
| James P. Maloney | MED | Common Stock | Award | 93.8% | 35,358 | 73,033 | 25 Mar 2026 | Direct | ||
| James P. Maloney | MED | Common Stock | Tax liability | -7.88% | -3,224 | 37,675 | 25 Mar 2026 | Direct | ||
| Daniel R. Chard | MED | Common Stock | Award | 28.5% | 41,795 | 188,233 | 25 Mar 2026 | Direct | ||
| Daniel R. Chard | MED | Common Stock | Tax liability | -12.1% | -20,095 | 146,438 | 25 Mar 2026 | Direct | ||
| Daniel R. Chard | MED | Common Stock | Purchase | $178,725 | $10.11 | 17,678 | 17,678 | 20 Mar 2026 | Dan and Allyson as Joint Tenants | |
| Jonathan Barrett MacKenzie | MED | Common Stock | Tax liability | -0.64% | -70 | 10,870 | 17 Mar 2026 | Direct | ||
| James P. Maloney | MED | Common Stock | Tax liability | -1.16% | -482 | 40,899 | 17 Mar 2026 | Direct | ||
| Daniel R. Chard | MED | Common Stock | Tax liability | -1.56% | -2,638 | 166,533 | 17 Mar 2026 | Direct | ||
| Jonathan Barrett MacKenzie | MED | Common Stock | Tax liability | -1.78% | -198 | 10,940 | 13 Mar 2026 | Direct | ||
| James P. Maloney | MED | Common Stock | Tax liability | -2.17% | -918 | 41,381 | 13 Mar 2026 | Direct | ||
| Daniel R. Chard | MED | Common Stock | Tax liability | -4.01% | -7,075 | 169,171 | 13 Mar 2026 | Direct |